Martin E. Schmieg

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ Martin E. Schmieg
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin E. Schmieg:

Company Role Class Num Shares Value Price $ Report Date Ownership
BriaCell Therapeutics Corp. Director Common Shares 575 $2,634 $4.58 01 Aug 2022 Direct

Insider Reports Filed by Martin E. Schmieg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCTX BriaCell Therapeutics Corp. 01 Aug 2022 0 $0 3 Director 01 Aug 2022, 16:10